USD 9.83
(1.29%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 87.15 Million USD | -5.21% |
2022 | 91.94 Million USD | 9.4% |
2021 | 84.04 Million USD | 27.85% |
2020 | 65.73 Million USD | 50.4% |
2019 | 43.7 Million USD | 85.77% |
2018 | 23.52 Million USD | 39.13% |
2017 | 16.9 Million USD | -0.85% |
2016 | 17.05 Million USD | -48.88% |
2015 | 33.36 Million USD | 16.82% |
2014 | 28.55 Million USD | 192.36% |
2013 | 9.76 Million USD | 7.34% |
2012 | 9.1 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 82.44 Million USD | -3.78% |
2024 Q1 | 85.68 Million USD | -1.68% |
2023 Q4 | 87.15 Million USD | -11.59% |
2023 Q1 | 98.05 Million USD | 6.64% |
2023 Q2 | 99.34 Million USD | 1.32% |
2023 Q3 | 98.57 Million USD | -0.78% |
2023 FY | 87.15 Million USD | -5.21% |
2022 Q3 | 88.29 Million USD | 2.38% |
2022 Q4 | 91.94 Million USD | 4.14% |
2022 FY | 91.94 Million USD | 9.4% |
2022 Q1 | 85.06 Million USD | 1.22% |
2022 Q2 | 86.23 Million USD | 1.38% |
2021 Q4 | 84.04 Million USD | 3.78% |
2021 Q3 | 80.97 Million USD | 3.73% |
2021 FY | 84.04 Million USD | 27.85% |
2021 Q2 | 78.06 Million USD | 16.68% |
2021 Q1 | 66.9 Million USD | 1.79% |
2020 Q4 | 65.73 Million USD | 26.28% |
2020 FY | 65.73 Million USD | 50.4% |
2020 Q3 | 52.05 Million USD | 4.93% |
2020 Q2 | 49.6 Million USD | 6.88% |
2020 Q1 | 46.41 Million USD | 6.2% |
2019 Q4 | 43.7 Million USD | 4.61% |
2019 FY | 43.7 Million USD | 85.77% |
2019 Q1 | 33.93 Million USD | 44.26% |
2019 Q2 | 36.46 Million USD | 7.45% |
2019 Q3 | 41.77 Million USD | 14.56% |
2018 Q4 | 23.52 Million USD | 18.8% |
2018 FY | 23.52 Million USD | 39.13% |
2018 Q1 | 18.24 Million USD | 7.88% |
2018 Q2 | 18.78 Million USD | 2.98% |
2018 Q3 | 19.8 Million USD | 5.41% |
2017 Q2 | 16.12 Million USD | -2.11% |
2017 Q1 | 16.47 Million USD | -3.41% |
2017 Q4 | 16.9 Million USD | 8.06% |
2017 FY | 16.9 Million USD | -0.85% |
2017 Q3 | 15.64 Million USD | -2.97% |
2016 Q3 | 22.12 Million USD | -12.4% |
2016 Q1 | 28.67 Million USD | -14.06% |
2016 Q2 | 25.25 Million USD | -11.91% |
2016 FY | 17.05 Million USD | -48.88% |
2016 Q4 | 17.05 Million USD | -22.92% |
2015 FY | 33.36 Million USD | 16.82% |
2015 Q2 | 24.03 Million USD | -9.39% |
2015 Q1 | 26.52 Million USD | -7.12% |
2015 Q4 | 33.36 Million USD | 48.37% |
2015 Q3 | 22.48 Million USD | -6.45% |
2014 Q3 | 9.77 Million USD | -3.46% |
2014 FY | 28.55 Million USD | 192.36% |
2014 Q4 | 28.55 Million USD | 192.15% |
2014 Q2 | 10.12 Million USD | 0.0% |
2013 Q4 | 9.76 Million USD | 0.0% |
2013 FY | 9.76 Million USD | 7.34% |
2012 FY | 9.1 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 5.35 Billion USD | 98.374% |
Addus HomeCare Corporation | 1.02 Billion USD | 91.493% |
AirSculpt Technologies, Inc. | 213.55 Million USD | 59.19% |
Amedisys, Inc. | 2.06 Billion USD | 95.77% |
American Oncology Network, Inc. | 374.45 Million USD | 76.726% |
Astrana Health, Inc. | 933.36 Million USD | 90.663% |
Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 94.677% |
IMAC Holdings, Inc. | 1.14 Million USD | -7517.29% |
biote Corp. | 155.29 Million USD | 43.88% |
Cryo-Cell International, Inc. | 61.22 Million USD | -42.355% |
Cross Country Healthcare, Inc. | 679.31 Million USD | 87.171% |
COMPASS Pathways plc | 275.98 Million USD | 68.422% |
DocGo Inc. | 490.45 Million USD | 82.231% |
The Ensign Group, Inc. | 4.17 Billion USD | 97.914% |
Healthcare Services Group, Inc. | 803.18 Million USD | 89.149% |
InnovAge Holding Corp. | 547.66 Million USD | 84.087% |
Assure Holdings Corp. | 7.51 Million USD | -1059.846% |
LifeStance Health Group, Inc. | 2.23 Billion USD | 96.098% |
Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -996.152% |
ModivCare Inc. | 1.76 Billion USD | 95.069% |
NewGenIvf Group Limited | 1.64 Million USD | -5190.014% |
Novo Integrated Sciences, Inc. | 35.56 Million USD | -145.06% |
Option Care Health, Inc. | 3.32 Billion USD | 97.382% |
P3 Health Partners Inc. | 860.96 Million USD | 89.878% |
P3 Health Partners Inc. | 860.96 Million USD | 89.878% |
The Pennant Group, Inc. | 539.69 Million USD | 83.852% |
Surgery Partners, Inc. | 7.01 Billion USD | 98.758% |
Syra Health Corp. Class A Common Stock | 4.92 Million USD | -1670.178% |
Talkspace, Inc. | 142.22 Million USD | 38.722% |
Talkspace, Inc. | 142.22 Million USD | 38.722% |
The Oncology Institute, Inc. | 219.41 Million USD | 60.281% |
The Oncology Institute, Inc. | 219.41 Million USD | 60.281% |